Product Description
Lixiana is indicated in prevention of stroke and systemic embolism in adult patients with nonvalvular atrial fibrillation (NVAF) with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack (TIA).
Lixiana is indicated in treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), and for the prevention of recurrent DVT and PE in adults
Directions
Available on request.Ingredients
Available on request.Product Details
Form:---Fridge-line:NoToxin:NoPOM:YesLegal Category:POMFiller:NoStorage Temperature:N/AManufacturer:N/A